Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Latest Generation of Products From Z-Medica - Hemostatic Gauze - Yields New At-Home Nosebleed Treatment

Abstract:
Every year in the United States, there are close to 400 million nosebleeds. While many nosebleeds are minor, about 515,000 result in visits to hospital emergency departments(1) -- stressful, time consuming and expensive incidents. Nosebleeds occur most frequently in two age groups, children two to ten years old, and seniors. Z-Medica Corp is now making a difference for mothers and caregivers to these loved ones with QuikClot(R) NoseBleed(TM) brand, a safe and economical new way to stop nasal bleeding.

Latest Generation of Products From Z-Medica - Hemostatic Gauze - Yields New At-Home Nosebleed Treatment

WALLINGFORD, CT | Posted on August 19th, 2008

QuikClot(R) NoseBleed(TM) brand, a gauze packing impregnated with a specially formulated substance that activates factors in blood to promote rapid blood coagulation, comes in an easy to apply and easy to remove format. It has been cleared by the FDA for over-the-counter use by anyone who can follow simple directions.

The packing is rolled or folded to fit into the affected nostril. Once inserted, pressure is applied and the bleeding should stop quickly. The new product is available online at http://www.quikclot.com where the Manufacturer's Suggested Retail Price (MSRP) for a box of five sterile applications is $11.49.

QuikClot(R) NoseBleed(TM) brand is manufactured by Z-Medica Corporation, a medical products company focused on innovative hemostatic nano-technologies. The company manufactures and markets several other life-saving products for use by its original markets -- the military, first responders, industrial first aid teams and law enforcement personnel. In addition to this new generation consumer product, the company also now offers online at www.quikclot.com other consumer products that stop bleeding for home, travel, sport and pet use.

####

For more information, please click here

Contacts:
Z-Medica Corp
4 Fairfield Blvd.
Wallingford, Connecticut 06492
(203) 294-0000

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Products

Spectradyne Partners with Particle Technology Labs for Measurement Services December 6th, 2018

Mode-Changing MEMS Accelerometer from STMicroelectronics Combines High Measurement Resolution and Ultra-Low Power for Industrial Applications November 7th, 2018

Fat-Repellent Nanolayers Can Make Oven Cleaning Easier October 17th, 2018

Aculon, Inc. Enters into Strategic Partnership Agreement with Henkel Corporation to Supply Key Mobile Device Manufacturers with NanoProof® PCB Waterproof Technology October 17th, 2018

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project